SERES THERAPEUTICS INC
MCRB · NASDAQ
更新於 2026-10-13 11:01:44
----
- 今日最高
- --
- 今日最低
- --
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $2.75
- 昨天收盤價
- $2.68
- 成交量
- 54.27K
- 市值
- $26.64M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-2.33
昨天價格區間
$2.66$2.78
52週價格區間
$2.42$29.98
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 生物科技
- 總部
- 101 CAMBRIDGEPARK DRIVE, CAMBRIDGE, MA, UNITED STATES, 02140
- 國家
- 美國
- 上市日期
- 2015-06-26
- 財年截止
- 十二月
- 流通股數
- 9.68M
- CIK
- 0001609809
Seres Therapeutics, Inc. 是一間微生物組治療平台公司，致力於開發旨在與宿主細胞和組織功能性相互作用以治療疾病的細菌聯合體。公司總部位於麻薩諸塞州劍橋。
財務指標
營業收入
2026-06-30
$736K
2026-03-31
$358K
2025-12-31
$438K
2025-09-30
$351K
營業支出
2026-06-30
$22M
2026-03-31
$21.26M
2025-12-31
$19.22M
2025-09-30
$22.09M
淨利潤
2026-06-30
$4.58M
2026-03-31
-$19.91M
2025-12-31
-$15.33M
2025-09-30
$8.2M
淨利潤率
2026-06-30
622.41%
2026-03-31
-5.56K%
2025-12-31
-3.5K%
2025-09-30
2.33K%
每股收益
2026-06-30
$-1.50
2026-03-31
$-2.08
2025-12-31
$-1.76
2025-09-30
$0.94
息稅折舊攤銷前利潤
2026-06-30
-$20.6M
2026-03-31
-$19.13M
2025-12-31
-$14.38M
2025-09-30
$9.24M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $736K | $358K | $438K | $351K |
| 營業支出 | $22M | $21.26M | $19.22M | $22.09M |
| 淨利潤 | $4.58M | -$19.91M | -$15.33M | $8.2M |
| 淨利潤率 | 622.41% | -5.56K% | -3.5K% | 2.33K% |
| 每股收益 | $-1.50 | $-2.08 | $-1.76 | $0.94 |
| 息稅折舊攤銷前利潤 | -$20.6M | -$19.13M | -$14.38M | $9.24M |
| 有效稅率 | -- | -- | -- | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。